ERBB2 and breast carcinoma: The dichotomy of biphasic survival probability between luminal and nonluminal Korean patients with breast cancer is substantially distinct from the clinical course of Caucasian breast cancer, where luminal A breast cancer shows the most indolent phenotype, followed by luminal B breast cancer and HER2 breast cancer, with the basal group having the highest risk patterns54.